Admera Health and Twist Bioscience Collaborate to Expand Next-Generation Sequencing Service Offerings Through Certified Partnership Program
January 7th, 2025, South Plainfield, New Jersey - Today, Admera Health, a premier Next-Generation Sequencing (NGS) service laboratory helping researchers advance their genetic-based initiatives, announced it is expanding its suite of services by partnering with Twist Bioscience as a certified NGS ProLab provider. Certified partnerships, like the Twist Bioscience ProLab program, require requisite training and are designed to ensure clients receive experimental results they can trust. Admera Health is a participant in five similar types of collaborations. In conjunction with these programs, Admera Health operates in a CAP/CLIA environment, adhering to the highest laboratory standards.
“Our partnership with Twist Bioscience reinforces our mission to equip researchers with state-of-the-art tools. Our collaboration underscores our dedication to providing innovative solutions that improve upon existing technologies to ensure we deliver our customers the highest-quality deliverables with expert support from our scientists.”
As part of the NGS ProLab program, Admera Health personnel were trained on the NEBNext® EM-seq™ Kit for Twist Targeted Methylation Sequencing. This novel epigenetic method of targeted methyl-seq is an enzymatic approach that minimizes DNA damage compared to traditional bisulfite conversion methods and targets specific genomic regions for high-throughput methylation analysis with high sensitivity.
Admera Health’s CEO, Yun Zhao, added, “Our partnership with Twist Bioscience reinforces our mission to equip researchers with state-of-the-art tools. Our collaboration underscores our dedication to providing innovative solutions that improve upon existing technologies to ensure we deliver our customers the highest-quality deliverables with expert support from our scientists.”
Admera Health welcomes the partnership with a promotion for their targeted methyl-seq service using the Twist Bioscience Methylation Detection System. More information about this promotion can be found on the company website.
About Admera Health:
Admera Health is a provider of advanced genomic and bioinformatic support that leverages Next-Generation Sequencing expertise for researchers in academia, biopharmaceutical, and animal health companies. Our team offers a comprehensive suite of genomic testing services for all species, including, WGS, RNAseq, WGBS, single-cell RNAseq, WES, and spatial transcriptomics as well as tailored solutions. All samples are managed with exceptional attention and upheld to the highest quality standards, being processed in a CLIA/CLEP-certified and CAP-accredited environment. Admera Health is committed to utilizing cutting-edge technology in research to deliver comprehensive data. Our team uses state-of-the-art platforms and tools for genomic sequencing, bioinformatics analysis, and data interpretation to provide the most accurate and reliable results possible.